Ozgur Yuksekdag

5PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersCheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 12, 2026
Metabolomic Analysis of Intracellular Amino Acid Profile Differences Between Cisplatin-Resistant and Cisplatin- Sensitive CALU-1 Lung Cancer Cells.

|Feb 07, 2024
Effective Anticancer Potential of a New Sulfonamide as a Carbonic Anhydrase IX Inhibitor Against Aggressive Tumors.

Ismail Koyuncu, Ebru Temiz, Eray Metin Güler

|Jun 06, 2022
Cedrus libani tar prompts reactive oxygen species toxicity and DNA damage in colon cancer cells.

Ebru Temiz, Kadir Eği, Ismail Koyuncu

|Feb 11, 2021
The Association Between BMP-2, UQCC1 and CX3CR1 Polymorphisms and the Risk of Developmental Dysplasia of the Hip.

Evren Gumus, Ebru Temiz, Baran Sarikaya

|Oct 27, 2018
Assessment of the antiproliferative and apoptotic roles of sulfonamide carbonic anhydrase IX inhibitors in HeLa cancer cell line.

Ismail Koyuncu, Ataman Gonel, Mustafa Durgun

Pageof 1

Frequent Collaborators

4 joint publications

Ismail Koyuncu

4 joint publications

Ebru Temiz

2 joint publications

Ataman Gonel

2 joint publications

Mustafa Durgun